Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_assertion type Assertion NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_head.
- NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_assertion description "[A total of 358 consecutive del(5q) cases were identified; specific diagnoses included myelodysplastic syndrome (MDS; 53%), acute myeloid leukemia (AML; 22%), plasma cell proliferative disorder (PCPD; 9%), myeloproliferative disorder (MPD; 7%), acute lymphoblastic leukemia (ALL; 2%), PCPD with MDS (2%), MDS/MPD (2%), and malignant lymphoma (ML; 2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_provenance.
- NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_assertion evidence source_evidence_literature NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_provenance.
- NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_assertion SIO_000772 17707907 NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_provenance.
- NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_assertion wasDerivedFrom befree-20140225 NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_provenance.
- NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_assertion wasGeneratedBy ECO_0000203 NP658369.RAvq2sZ1VCpGrfeKNdwHGg-uwKiY2XD5WwEvKraMiXdMA130_provenance.